The fight against cancer is increasingly relying on sophisticated chemical interventions, with targeted therapies playing a significant role. Palbociclib stands out as a prime example – a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) that has revolutionized the treatment of certain types of breast cancer. The development and availability of such life-saving drugs are deeply rooted in the precise science of organic chemistry and the reliable supply of pharmaceutical intermediates.

At the heart of Palbociclib's synthesis lies a crucial chemical compound: 2-Chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyrimidin-7(8H)-one, identified by CAS number 1013916-37-4. This molecule, often sourced as a yellow powder, is not just a precursor but a complex building block that dictates the efficiency and success of the entire Palbociclib manufacturing process. NINGBO INNO PHARMCHEM CO., LTD. is committed to providing this essential intermediate to researchers and pharmaceutical manufacturers worldwide.

Understanding the Palbociclib intermediate synthesis is key to appreciating the value of compounds like CAS 1013916-37-4. Its specific structure, represented by the molecular formula C13H14ClN3O, is designed to undergo specific reactions that ultimately lead to the formation of Palbociclib. The chemical properties of this intermediate, including its solubility and reactivity, are carefully managed to ensure optimal outcomes in the laboratory and production settings. When clients seek to buy 2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one online, they are often looking for a partner who guarantees these critical attributes.

Beyond its role as a direct intermediate, the compound also appears as a Palbociclib impurity. This dual identity underscores the importance of purity and analytical precision in pharmaceutical chemistry. Ensuring that this specific compound is either efficiently converted or meticulously removed is part of the rigorous quality control that defines modern drug production. NINGBO INNO PHARMCHEM CO., LTD. plays a vital role in this by supplying high-purity API intermediate materials, coupled with comprehensive documentation such as Certificates of Analysis.

The ongoing research into cancer treatment and the development of new therapies depend heavily on the availability of specialized chemical compounds. By focusing on the reliable supply of intermediates like 2-Chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyrimidin-7(8H)-one, NINGBO INNO PHARMCHEM CO., LTD. contributes to the advancement of cancer care. Our dedication to quality and our understanding of the complex chemical properties of C13H14ClN3O position us as a valuable partner in the pharmaceutical supply chain.